(Q39438422)

12 September 2017

Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents (English)

1 reference

12 September 2017

0 references

3

1 reference

12 September 2017

Antonietta Vilella

4

0 references

Barbara Ruozi

Barbara Ruozi

2

0 references

Flavio Forni

Flavio Forni

7

0 references

Maria Angela Vandelli

Maria Angela Vandelli

6

0 references

Giovanni Tosi

Giovanni Tosi

1

0 references

Michele Zoli

Michele Zoli

5

0 references

publication date

8 April 2013

1 reference

12 September 2017

1 reference

12 September 2017

8

1 reference

12 September 2017

9

1 reference

12 September 2017

1373-1383

1 reference

Nanomedicine: current status and future prospects.

12 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Drug delivery and nanoparticles:applications and hazards

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Improvement of drug safety by the use of lipid-based nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanomedicine: sizing up targets with nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Modeling particle shape-dependent dynamics in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

The effect of nanoparticle size, shape, and surface chemistry on biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Seven challenges for nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Tumour-targeted nanomedicines: principles and practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Drug delivery via the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Polymeric nanoparticles for the drug delivery to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanomedicine: the future for advancing medicine and neuroscience.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Complement system and the brain: selected pathologies and avenues toward engineering of neurological nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Challenges in drug delivery to the brain: nature is against us.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Characteristics of compounds that cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

The emerging nanomedicine landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Transport of drugs across the blood-brain barrier by nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Potential of nanoparticulate drug delivery systems by intranasal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

The journey of a drug-carrier in the body: an anatomo-physiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Administration, distribution, metabolism and elimination of polymer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Route of administration-dependent anti-inflammatory effect of liposomal alendronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

The transport barrier in intraperitoneal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nanoparticles for direct nose-to-brain delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Modulation of nucleic acid structure by ligand binding: induction of a DNA.RNA.DNA hybrid triplex by DAPI intercalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Glycosylated neuropeptides: a new vista for neuropsychopharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Nasal drug delivery - recent developments and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Body distribution of azidothymidine bound to nanoparticles after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood–brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.12.172

21 January 2018

Identifiers

DOI

10.2217/NNM.12.172

1 reference

12 September 2017

1 reference

PubMed ID

23565661